東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Cannabis Substitution for Prescripti...

Strand, Lauren.

FindBook

Google Book

Amazon

博客來

Cannabis Substitution for Prescription Drugs: Understanding Longitudinal Trends in the Era of Legal Cannabis.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Cannabis Substitution for Prescription Drugs: Understanding Longitudinal Trends in the Era of Legal Cannabis./
作者:	Strand, Lauren.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2021,
面頁冊數:	161 p.
附註:	Source: Dissertations Abstracts International, Volume: 82-11, Section: B.
Contained By:	Dissertations Abstracts International82-11B.
標題:	Law. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28412290
ISBN:	9798728230670

Cannabis Substitution for Prescription Drugs: Understanding Longitudinal Trends in the Era of Legal Cannabis.
Strand, Lauren.

Cannabis Substitution for Prescription Drugs: Understanding Longitudinal Trends in the Era of Legal Cannabis. - Ann Arbor : ProQuest Dissertations & Theses, 2021 - 161 p.

Source: Dissertations Abstracts International, Volume: 82-11, Section: B.

Thesis (Ph.D.)--University of Washington, 2021.

The effects of changes in cannabis laws continue to be of great interest to researchers, medical professionals, and policymakers as individual US states implement legal cannabis markets and cannabinoids are better studied. Cannabis may serve as a substitute for a number of substances including several classes of prescription drugs. In order to evaluate cannabis-for-prescription drug substitution in the period following legal dispensary opening in Washington State (July 2014-December 2017), we evaluated the effect of increased cannabis demand on opioid dispensing outcomes in individual counties. We instrumented county-quarter level cannabis sales using state-regulated dispensary density, estimating within-county changes in the number of individuals dispensed opioids per quarter. Effects of increasing retail cannabis sales on short- and long-term dispensing were small in magnitude and not statistically significant. Small effects for long-term high dose dispensing (approximately 3% of dispensing) may reflect substitution among the individuals at the highest risk for opioid use disorder; however, we did not find consistent evidence for substitution in the early period during recreational cannabis rollout in Washington. We also evaluated post-cannabis policy change substitution effects for antianxiety and antidepressant medication use in their respective indications among individuals with employer-sponsored insurance within US states (2010-2017). Medical cannabis policy did not lead to measurable changes in the level of use of antianxiety medications or antidepressants within their respective conditions; however, there may be noteworthy state and time-related heterogeneity as evidenced in event studies. In synthetic control models for Colorado and Washington, which legalized recreational cannabis in 2012, the use of antianxiety medications in anxiety and antidepressants in depression was not impacted by recreational cannabis policy change. Together, these findings may reflect little substitution for these classes in the first few years after cannabis policy enactment.

ISBN: 9798728230670Subjects--Topical Terms:

600858
Law.
Subjects--Index Terms:

Cannabis

Cannabis Substitution for Prescription Drugs: Understanding Longitudinal Trends in the Era of Legal Cannabis.
LDR:03270nmm a2200397 4500 001 2401186
005 20241022112056.5
006 m o d
007 cr#unu||||||||
008 251215s2021 ||||||||||||||||| ||eng d
020 $a 9798728230670
035 $a (MiAaPQ)AAI28412290
035 $a AAI28412290
035 $a 2401186
040 $a MiAaPQ $c MiAaPQ
100 1 $a Strand, Lauren. $3 3771264
245 1 0 $a Cannabis Substitution for Prescription Drugs: Understanding Longitudinal Trends in the Era of Legal Cannabis.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 161 p.
500 $a Source: Dissertations Abstracts International, Volume: 82-11, Section: B.
500 $a Advisor: Hansen, Ryan.
502 $a Thesis (Ph.D.)--University of Washington, 2021.
520 $a The effects of changes in cannabis laws continue to be of great interest to researchers, medical professionals, and policymakers as individual US states implement legal cannabis markets and cannabinoids are better studied. Cannabis may serve as a substitute for a number of substances including several classes of prescription drugs. In order to evaluate cannabis-for-prescription drug substitution in the period following legal dispensary opening in Washington State (July 2014-December 2017), we evaluated the effect of increased cannabis demand on opioid dispensing outcomes in individual counties. We instrumented county-quarter level cannabis sales using state-regulated dispensary density, estimating within-county changes in the number of individuals dispensed opioids per quarter. Effects of increasing retail cannabis sales on short- and long-term dispensing were small in magnitude and not statistically significant. Small effects for long-term high dose dispensing (approximately 3% of dispensing) may reflect substitution among the individuals at the highest risk for opioid use disorder; however, we did not find consistent evidence for substitution in the early period during recreational cannabis rollout in Washington. We also evaluated post-cannabis policy change substitution effects for antianxiety and antidepressant medication use in their respective indications among individuals with employer-sponsored insurance within US states (2010-2017). Medical cannabis policy did not lead to measurable changes in the level of use of antianxiety medications or antidepressants within their respective conditions; however, there may be noteworthy state and time-related heterogeneity as evidenced in event studies. In synthetic control models for Colorado and Washington, which legalized recreational cannabis in 2012, the use of antianxiety medications in anxiety and antidepressants in depression was not impacted by recreational cannabis policy change. Together, these findings may reflect little substitution for these classes in the first few years after cannabis policy enactment.
590 $a School code: 0250.
650 4 $a Law. $3 600858
650 4 $a Pharmaceutical sciences. $3 3173021
653 $a Cannabis
653 $a Claims
653 $a Medication
653 $a Opioid
653 $a Policy
653 $a Substitution
690 $a 0398
690 $a 0572
710 2 $a University of Washington. $b Pharmacy. $3 3186017
773 0 $t Dissertations Abstracts International $g 82-11B.
790 $a 0250
791 $a Ph.D.
792 $a 2021
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28412290